Impact of GneXpert MTB/RIF on TB outcomes in an ART clinic

Preventing TB-related adverse outcomes in patients initiating ART: the impact of Xpert MTB/RIF

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201303000505764

Enrollment

400

Registered

2013-02-19

Start date

2011-07-25

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV/AIDS Tuberculosis

Interventions

Xpert MTB/RIF

Fluorescent microscopy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - aged 18 years or older - HIV positive eligible for ART

Exclusion criteria

Exclusion criteria: - on ART - on TB treatment/treated in the past 6 months - seriously ill (fever >38oC, respiratory rate >30 beats/minute and unable to walk unaided)

Design outcomes

Primary

Measure	Time frame
Adverse outcome	—

Secondary

Measure	Time frame
-diagnostic yield of sputum induction ;Risk factors for adverse outcome;Burden of TB in asymptomatic patients	—

Countries

Zimbabwe

Contacts

Public ContactPeter Mason

Director

pmason@brti.co.zw+263-4735000

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026